• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

10.04 -0.24 (-2.33%)
Streaming Delayed Price Updated: 1:16 PM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 300,839
Open 10.28
Bid (Size) 10.01 (1,500)
Ask (Size) 10.04 (200)
Prev. Close 10.28
Today's Range 9.780 - 10.29
52wk Range 3.435 - 17.65
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER
July 21, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 14, 2026
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-38.7%
-38.7%
1 Month
-4.2%
-4.2%
3 Month
-25.7%
-25.7%
6 Month
-17.4%
-17.4%
1 Year
+162.8%
+162.8%

More News

Read More
News headline image
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? ↗
July 08, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
July 08, 2026
From Schall Law
Via GlobeNewswire
Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts ↗
May 13, 2026
Via Chartmill
Omeros Corp (NASDAQ:OMER) Reports Q4 2025 Earnings Boosted by Major Asset Sale, Launches First Commercial Product ↗
March 31, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 07, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
July 06, 2026
From The Schall Law Firm
Via Business Wire
Which stocks are moving on Friday? ↗
June 26, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
June 26, 2026
Via Chartmill
Top movers in Friday's pre-market session ↗
June 26, 2026
Via Chartmill
News headline image
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
June 26, 2026
From Omeros Corporation
Via Business Wire
News headline image
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗
June 22, 2026
Via The Motley Fool
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
June 20, 2026
Via The Motley Fool
News headline image
Omeros Announces Webcast Details for Annual Meeting of Shareholders
June 15, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros (OMER) Q4 2025 Earnings Transcript ↗
June 01, 2026
Via The Motley Fool
Topics Derivatives
News headline image
Omeros (OMER) Q1 2026 Earnings Transcript ↗
May 14, 2026
Via The Motley Fool
News headline image
Omeros Q1 Earnings Call Highlights ↗
May 14, 2026
Via MarketBeat
Topics Earnings
News headline image
Omeros Corporation Reports First Quarter 2026 Financial Results
May 13, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
May 11, 2026
From Omeros Corporation
Via Business Wire
News headline image
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
April 20, 2026
From Sagimet Biosciences Inc.
Via GlobeNewswire
News headline image
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
April 16, 2026
From Omeros Corporation
Via Business Wire
These stocks are gapping in today's session ↗
April 01, 2026
Via Chartmill
News headline image
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
March 31, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
March 26, 2026
From Omeros Corporation
Via Business Wire

Frequently Asked Questions

Is Omeros Corporation - Common Stock publicly traded?
Yes, Omeros Corporation - Common Stock is publicly traded.
What exchange does Omeros Corporation - Common Stock trade on?
Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omeros Corporation - Common Stock?
The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
What is the current price of Omeros Corporation - Common Stock?
The current price of Omeros Corporation - Common Stock is 10.04
When was Omeros Corporation - Common Stock last traded?
The last trade of Omeros Corporation - Common Stock was at 07/24/26 01:16 PM ET
What is the market capitalization of Omeros Corporation - Common Stock?
The market capitalization of Omeros Corporation - Common Stock is 631.07M
How many shares of Omeros Corporation - Common Stock are outstanding?
Omeros Corporation - Common Stock has 631M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap